"Making these popular drugs more affordable will help seniors live healthier lives," a CMS spokesperson said
While dose adjustment is not generally required for mild to moderate renal or hepatic impairment, tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is not recommended in these populations
Before initiating compounded semaglutide, patients benefit from understanding potential injection site reactions, gastrointestinal adaptation, and the typical 412 week timeline for therapeutic response
Each medication has other, demonstrated positive health impacts (see the chart below), which can also drive the decision to use one over the other
Going slower is always acceptable